Clinical Trials List
2024-08-01 - 2027-12-31
Phase III
Recruiting6
ICD-10E78.1
Pure hyperglyceridemia
ICD-9272.1
Pure hyperglyceridemia
-
Trial Applicant
MEDPACE TAIWAN LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 陳隆景 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ye-Hsu Lu 無
- Mei Yueh Lee 無
- Po-Chao Hsu 無
- 吳韋璁 無
- Jui-Sheng Hsu 無
- Chun-Yuan Chu 無
- 洪薇雯 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 黃睦翔 無
- 杜業豐 無
- Po-Tseng Lee 無
- 黃鼎鈞 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
50 participants
-
Global
800 participants